Anna Aakula
anna.aakula@bioscience.fi +358 29 450 3788 +358 50 571 3729 |
Publications
- PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers (2023)
- Molecular Oncology
(Refereed journal article or data article (A1)) - RAS and PP2A activities converge on epigenetic gene regulation (2023)
- Life Science Alliance
(Refereed journal article or data article (A1)) - Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A (2023)
- Nature Communications
(Refereed journal article or data article (A1)) - Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 (2020)
- Journal of Biological Chemistry
(Refereed journal article or data article (A1)) - Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer (2019)
- Cancer Research
(Other (O2)) - PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (2018)
- Science Translational Medicine
(Refereed journal article or data article (A1)) - MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth (2015)
- Molecular Oncology
(Refereed journal article or data article (A1))